A Single Session of Virtual Reality Improved Tiredness, Shortness of Breath, Anxiety, Depression and Well-Being in Hospitalized Individuals with COVID-19: A Randomized Clinical Trial
Overview
Authors
Affiliations
Background: In 2020, the world was surprised by the spread and mass contamination of the new Coronavirus (COVID-19). COVID-19 produces symptoms ranging from a common cold to severe symptoms that can lead to death. Several strategies have been implemented to improve the well-being of patients during their hospitalization, and virtual reality (VR) has been used. However, whether patients hospitalized for COVID-19 can benefit from this intervention remains unclear. Therefore, this study aimed to investigate whether VR contributes to the control of pain symptoms, the sensation of dyspnea, perception of well-being, anxiety, and depression in patients hospitalized with COVID-19.
Methods: A randomized, double-blind clinical trial was designed. Patients underwent a single session of VR and usual care. The experimental group ( = 22) received VR content to promote relaxation, distraction, and stress relief, whereas the control group ( = 22) received non-specific VR content.
Results: The experimental group reported a significant decrease in tiredness, shortness of breath, anxiety, and an increase in the feeling of well-being, whereas the control group showed improvement only in the tiredness and anxiety.
Conclusions: VR is a resource that may improve the symptoms of tiredness, shortness of breath, anxiety, and depression in patients hospitalized with COVID-19. Future studies should investigate the effect of multiple VR sessions on individuals with COVID-19.
The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea.
Gao B, Wang S, Jiang S Med Rev (2021). 2024; 4(5):395-412.
PMID: 39444798 PMC: 11495473. DOI: 10.1515/mr-2024-0006.
Immersive Virtual Reality Use in Medical Intensive Care: Mixed Methods Feasibility Study.
Locke B, Tsai T, Mahony Reategui-Rivera C, Gabriel A, Smiley A, Finkelstein J JMIR Serious Games. 2024; 12:e62842.
PMID: 39046869 PMC: 11344185. DOI: 10.2196/62842.
Immersive Technologies for Depression Care: Scoping Review.
Mahony Reategui-Rivera C, Villarreal-Zegarra D, De la Cruz-Torralva K, Diaz-Sanchez P, Finkelstein J JMIR Ment Health. 2024; 11:e56056.
PMID: 38663004 PMC: 11082738. DOI: 10.2196/56056.
Fung V, Chan J, Ching Chui E, Wong C, Chu R, So Y BMC Psychiatry. 2024; 24(1):271.
PMID: 38609962 PMC: 11010282. DOI: 10.1186/s12888-024-05690-7.
Alhammad S Patient Prefer Adherence. 2024; 18:695-707.
PMID: 38524197 PMC: 10960537. DOI: 10.2147/PPA.S451609.